Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility

Keyphrases

• Tumor Susceptibility 100%
• Gonadotrope 100%
• Pituitary Tumor 100%
• PROP1 100%
• Tumor 33%
• Thyrotrope 33%
• Cell Differentiation 16%
• Cell Proliferation 16%
• Terminal Differentiation 16%
• Aged Mice 16%
• Pituitary 16%
• Pituitary Cells 16%
• Constitutive Expression 16%
• Deregulation 16%
• Anterior pituitary Cells 16%
• Gain-of-function mutation 16%
• Hormone-producing Cells 16%
• Differentiation Markers 16%
• Pituitary Function 16%
• Adenomatous Hyperplasia 16%
• Endocrinopathy 16%
• Primordia 16%
• Pituitary Gonadotropes 16%
• Anterior pituitary Gland 16%
• Puberty Onset 16%
• Pituitary Development 16%
• Homeodomain Transcription Factor 16%
• Rathke Cleft Cyst 16%
• Hypogonadism 16%
• Human pituitary 16%
• Mild Hypothyroidism 16%

Medicine and Dentistry

• Neoplasm 100%
• Pituitary Tumour 100%
• Cancer Susceptibility 100%
• Transcription Factors 50%
• Cell Differentiation 50%
• Cell Proliferation 50%
• Adenoma 50%
• Primordium 50%
• Hypothyroidism 50%
• Endocrine Disease 50%
• Pituitary Gland 50%
• Rathke Cleft Cyst 50%
• Gain of Function Mutation 50%
• Hypogonadism 50%

Neuroscience

• Anterior Pituitary 100%
• Pituitary Tumour 100%
• Transcription Factors 50%
• Cell Proliferation 50%
• Pituitary Gland 50%
• Cellular Differentiation 50%
• Cleft 50%
• Hypothyroidism 50%
• Gain of Function Mutation 50%
• PROP1 50%
• Hyperplasia 50%
• Hypogonadism 50%
• Endocrine Disease 50%